search
Back to results

Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

Primary Purpose

Stroke, Weakness of Extremities as Sequela of Stroke

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Indego Exoskeleton
Standard Rehabilitation
Sponsored by
University of Oklahoma
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke, leg weakness, Exoskeleton

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. All patients with acute hemorrhagic or ischemic stroke documented clinically and by neuroimaging.
  2. Medically stable from a cardio-respiratory stand point so that they can participate in daily therapies.
  3. Depressed patients will be included in the study
  4. Patients able to stand alone
  5. Patients able to provide a written informed consent, from cognitively intact patients (admission Mini Mental Scale Examination [MMSE] greater than or equal to 21).

Exclusion Criteria:

  1. Aphasic patients unable to communicate
  2. Confused patients
  3. Patients medically unstable
  4. Patients unable to stand alone
  5. Refusal to provide written informed consent

Sites / Locations

  • Oklahoma City VA Health Care SystemRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Exo-group

Control-Group

Arm Description

Standard rehabilitation plus use of Exoskeleton

Standard rehabilitation

Outcomes

Primary Outcome Measures

The Functional Independence Measure (FIM™)
It measure the degree of disability as well as the progress patients make throughout their medical rehabilitation programs. FIM Scale score varies from minimum of 18 to maximum of 126. Higher score better the outcome.
The two minute walk test (2-MWT)
It assess the walking distance over two minutes while moving at a comfortable speed. using any ambulation aids (such as cane, walkers, and rollators) used in everyday life. Normal walking speed is 360 ft.

Secondary Outcome Measures

Modified Ashworth Scale (MAS)
Clinical measure of degree of spasticity. Score varies from 0=normal tome to 4=part rigid in flexion and extension. Lower the score the better the outcome.
Discharge disposition
Looks at effectiveness of rehabilitation as to how many patients are discharged home. Higher percentage 65% and above the better outcome.
The Beck Depression Inventory (BDI)
It is a 21 item self-report rating inventory measuring characteristic attitudes and symptoms of depression. It ranges in value from 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-offs are as follows: 0-9 indicates person is not depressed, 10-18 indicates mild-moderate depression, 19-29 indicates moderate-severe depression and 30-63 indicates severe depression.

Full Information

First Posted
May 2, 2019
Last Updated
May 17, 2022
Sponsor
University of Oklahoma
search

1. Study Identification

Unique Protocol Identification Number
NCT03980457
Brief Title
Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke
Official Title
Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
September 1, 2026 (Anticipated)
Study Completion Date
September 1, 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Oklahoma

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this study is to determine the efficacy of electromechanical exoskeleton-assisted gait training on rehabilitation functional outcomes in patients with stroke undergoing therapy in an in-patient rehabilitation facility.
Detailed Description
Abstract Objective: The goal of this study is to determine the efficacy of electromechanical exoskeleton-assisted gait training on rehabilitation functional outcomes in patients with stroke undergoing therapy in an in-patient rehabilitation facility. Background: Method: The investigators will study 50 patients with stroke consecutively admitted to a designated stroke rehabilitation unit in the Oklahoma City VA Medical Center. All patients will receive their daily 3-hours conventional therapy, plus an hour of either exoskeleton or over-ground gait training 3 times per week for 60 minutes. Patients were assigned to either the experimental (exoskeleton) or the control (over-ground) groups by computer-generated randomization. This is an open-label pragmatic trial, where neither the patients nor the clinicians could be masked to the intervention. Institution review board (IRB) approval will be obtained for the protocol. The demographic data to be collected includes: age, gender, race/ethnicity, stroke onset to admission, stroke types (ischemic/hemorrhagic), and stroke severity (on the National Institute of Health Stroke Severity [NIHSS] scale. Admission and discharge total Functional Independence Measure (FIM), spasticity and depression scores, ambulation velocity over 2-minutes (2-MWT) in feet/minute, and discharge disposition. The intervention is Indego® exoskeleton. The primary outcome measures were: changes in the FIM, depression and spasticity scores. The secondary outcome measure was discharge disposition. Continuous variables were analyzed using Students t-test, ordinal variables were analyzed using Mann-Whitney, and the nominal variables were analyzed using Chi-square analyses.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Weakness of Extremities as Sequela of Stroke
Keywords
Stroke, leg weakness, Exoskeleton

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Open label pragmatic study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exo-group
Arm Type
Experimental
Arm Description
Standard rehabilitation plus use of Exoskeleton
Arm Title
Control-Group
Arm Type
Placebo Comparator
Arm Description
Standard rehabilitation
Intervention Type
Device
Intervention Name(s)
Indego Exoskeleton
Intervention Description
Powered generated orthosis
Intervention Type
Other
Intervention Name(s)
Standard Rehabilitation
Intervention Description
Standard Rehabilitation
Primary Outcome Measure Information:
Title
The Functional Independence Measure (FIM™)
Description
It measure the degree of disability as well as the progress patients make throughout their medical rehabilitation programs. FIM Scale score varies from minimum of 18 to maximum of 126. Higher score better the outcome.
Time Frame
Baseline (Day 1) and at 4-weeks to measure change
Title
The two minute walk test (2-MWT)
Description
It assess the walking distance over two minutes while moving at a comfortable speed. using any ambulation aids (such as cane, walkers, and rollators) used in everyday life. Normal walking speed is 360 ft.
Time Frame
Baseline (Day 1) and at 4-weeks to measure change
Secondary Outcome Measure Information:
Title
Modified Ashworth Scale (MAS)
Description
Clinical measure of degree of spasticity. Score varies from 0=normal tome to 4=part rigid in flexion and extension. Lower the score the better the outcome.
Time Frame
Baseline (Day 1) and at 4-weeks to measure change
Title
Discharge disposition
Description
Looks at effectiveness of rehabilitation as to how many patients are discharged home. Higher percentage 65% and above the better outcome.
Time Frame
4-weeks
Title
The Beck Depression Inventory (BDI)
Description
It is a 21 item self-report rating inventory measuring characteristic attitudes and symptoms of depression. It ranges in value from 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-offs are as follows: 0-9 indicates person is not depressed, 10-18 indicates mild-moderate depression, 19-29 indicates moderate-severe depression and 30-63 indicates severe depression.
Time Frame
Baseline (Day 1) and at 4-weeks to measure change

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients with acute hemorrhagic or ischemic stroke documented clinically and by neuroimaging. Medically stable from a cardio-respiratory stand point so that they can participate in daily therapies. Depressed patients will be included in the study Patients able to stand alone Patients able to provide a written informed consent, from cognitively intact patients (admission Mini Mental Scale Examination [MMSE] greater than or equal to 21). Exclusion Criteria: Aphasic patients unable to communicate Confused patients Patients medically unstable Patients unable to stand alone Refusal to provide written informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Meheroz H Rabadi, MD, MRCPI
Phone
405-456-5298
Email
rabadimh@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Meheroz H Rabadi, MD, MRCPI
Organizational Affiliation
Affiliate; Oklahoma VA Health Care System
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oklahoma City VA Health Care System
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meheroz Rabadi, MD, MRCPI
Phone
405-456-5298
Email
meheroz.rabadi@va.gov
First Name & Middle Initial & Last Name & Degree
Meheroz Rabadi, MD, MRCPI

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

We'll reach out to this number within 24 hrs